Sfoglia per Autore
Identification of a novel t(1;9)(q11;q34) in acute myelocytic leukemia
2004 PICCALUGA PP; LUATTI S; ASCANI S; BIANCHINI M; MALAGOLA M; RONDONI M; GAITANI S; TESTONI N.; PILERI SA; BACCARANI M; MARTINELLI G; VISANI G
Low dose gemtuzumab ozogamicin for relapsed acute myeloid leukaemia in elderly
2004 Piccaluga, Pier Paolo; Martinelli, Giovanni; Rondoni, Michela; Malagola, Michele; Ronconi, Sonia; Visani, Giuseppe; Baccarani, Michele
Gemtuzumab ozogamicin plus cytarabine determines complete remission in acute myeloid leukemia refractory to a double conventional treatment: a case report.
2004 Mele A; Sparaventi G; Guiducci B; Nicolini G; d'Adamo F; Leopardi G; Delfini C; Piccaluga P; Visani G.
The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis.
2005 van der Holt B; Lowenberg B; Burnett AK; Knauf WU; Shepherd J; Piccaluga PP; Ossenkoppele GJ; Verhoef GE; Ferrant A; Crump M; Selleslag D; Theobald M; Fey MF; Vellenga E; Dugan M; Sonneveld P.
Impiego del pegfilgrastim in associazione cn R-CHOP in un paziente critico affetto da un linfoma non Hodgkin aggressivo primitivo del cuore.
2005 Vigna E; Placci A; Laterza C; Agostinelli C; Papayannidis C; Martinelli G; Pileri SA; Piccaluga PP.
Fattibilità ed efficacia del regime chemioterapico My-Flaig (mylotarg, fludarabina, citosina arabinsoide, idarubicina e pegfilgrastim) nella terapia della leucemia acuta mieloide.
2005 Piccaluga PP; Vigna E; Martinelli G.
Gene Expression analysis of Peripheral T-Cell Lympoma Not Otherwise Specified Reveals the Existance of Two Subgroups Related to Different Celular Counterparts and Recurrent PDGFRA Deregulation.
2005 Piccaluga P.P.; Agostinelli C.; Zupo S.; Califano A.; Went P.; Ascani S.; Basso K.; Facchetti F.; Falini B.; Ferrarini M.; Gallamini A.; Klein U.; Novero D.; Paulli M.; Tura S.; Zinzani PL.; Baccarani M.; Dalla-Favera R.; Pileri SA.
Marker expression in Peripheral T-Cell Lymphoma Unspecified: Proposal of a Clinical-Pathologic Prognostic Score.
2005 Piccaluga PP.; Went P.; Agostinelli C.; Gallamini A.; Ascani S.; Sabattini E.; Bacci F.; Falini B.; Motta T.; Paulli M.; Artusi T.; Zinzani PL.; Baccarani M.; Pileri SA.
Expression of platelet-derived growth factor receptor alpha in peripheral T-cell lymphoma not otherwise specified
2005 Piccaluga PP; Agostinelli C; Zinzani PL; Baccarani M; Dalla Favera R; Pileri SA.
Mini-ICE effectively mobilises peripheral blood stem cells after fludarabine-based regimens in acute myeloid leukaemia.
2005 Mele A; Leopardi G; Sparaventi G; Nicolini G; D'Adamo F; Guiducci B; Barulli S; Malerba L; Stramigioli S; Talevi N; Politi P; Isidori A; Malagola M; Piccaluga P; Visani G.
Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients
2005 Russo D; Malagola M; Vivo A; Fiacchini M; Martinelli G; Piccaluga PP; Damiani D; Candoni A; Michielutti A; Castelli M; Testoni N; Ottaviani E; Rondoni M; Pricolo G; Mazza P; Zuffa E; Zaccaria A; Raspadori D; Bocchia M; Lauria F; Bonini A; Avanzini P; Gugliotta L; Visani G; Fanin R; Baccarani M
The development of more than one histologic type of lymphoma in the same patient is frequent and confers a worse prognosis
2005 Pileri S.A.; Piccaluga P.P.; Sabattini E.; Zinzani P.L.
Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays.
2005 ZINZANI P.; DIRNHOFER S; SABATTINI E; ALINARI L; PICCALUGA PP; STEFONI V; TANI M; MUSURACA G; MARCHI E; FALINI B; BACCARANI M; PILERI SA.
Imatinib mesylate in the treatment of c-kit-positive acute myeloid leukemia: is this the real target?
2005 Malagola M; Martinelli G; Rondoni M; Paolini S; Gaitani S; Arpinati M; Piccaluga PP; Amabile M; Basi C; Ottaviani E; Candoni A; Gottardi E; Cilloni D; Bocchia M; Saglio G; Lauria F; Fanin R; Visani G; Marre MC; Maderna M; Rancati F; Vinaccia V; Russo D; Baccarani M.
Alemtuzumab in the treatment of relapsed acute lymphoid leukaemia.
2005 PICCALUGA PP; MARTINELLI G; MALAGOLA M; RONDONI M; BONIFAZI F; BANDINI G; VISANI G; BACCARANI M.
Strategies in the treatment of acute myeloid leukemia.
2005 Martinelli G; Malagola M; Rondoni M; Piccaluga PP; Bosi C; Russo D; Baccarani M.
Cyclophosphamide, pegylated liposomal doxorubicin, vincristine and prednisone (CDOP) plus rituximab is effective and well tolerated in poor performance status elderly patients with non-Hodgkin's lymphoma.
2005 Visani G; Guiducci B; D'Adamo F; Mele A; Nicolini G; Leopardi G; Sparaventi G; Barulli S; Malerba L; Isidori A; Malagola M; Piccaluga PP.
Gene expression analysis of peripheral T-cell lymphoma not otherwise specified reveals two distinct subgroups and recurrent PDGFRa deregulation. It's time to take care of peripheral T-cell lymphoma.
2006 Pileri S.A.; Piccaluga PP.; Agostinelli C.; Zupo S.; Carbone A.; Facchetti F.; Falini B.; Ferrarini M.; Gallamini A.; Novero D.; Paulli M.; Zinzani P.L.; Dalla Favera R.
Gene expression analysis of peripheral t-cell lymphoma not otherwise specified reveals two distint subgroups and recurrent PDGFRa; deregulation.
2006 Pileri S.A.; Piccaluga P.P.; Agostinelli C.; Zupo S.; Facchetti F.; Falini B.; Ferrarini M.; Novero D.; Palli M.; Zinzani P.L.; Dalla Favera R.
Poor outcome of adult acute lymphoblastic leukemia patients carrying the (1;19)(q23;p13) translocation.
2006 Piccaluga PP; Malagola M; Rondoni M; Ottaviani E; Testoni N; Laterza C; Visani G; Pileri SA; Martinelli G; Baccarani M.
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Identification of a novel t(1;9)(q11;q34) in acute myelocytic leukemia | PICCALUGA PP; LUATTI S; ASCANI S; BIANCHINI M; MALAGOLA M; RONDONI M; GAITANI S; TESTONI N.; PILE...RI SA; BACCARANI M; MARTINELLI G; VISANI G | 2004-01-01 | CANCER GENETICS AND CYTOGENETICS | - | 1.01 Articolo in rivista | - |
| Low dose gemtuzumab ozogamicin for relapsed acute myeloid leukaemia in elderly | Piccaluga, Pier Paolo; Martinelli, Giovanni; Rondoni, Michela; Malagola, Michele; Ronconi, Sonia;... Visani, Giuseppe; Baccarani, Michele | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | ECR37.full.pdf |
| Gemtuzumab ozogamicin plus cytarabine determines complete remission in acute myeloid leukemia refractory to a double conventional treatment: a case report. | Mele A; Sparaventi G; Guiducci B; Nicolini G; d'Adamo F; Leopardi G; Delfini C; Piccaluga P; Visa...ni G. | 2004-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| The value of the MDR1 reversal agent PSC-833 in addition to daunorubicin and cytarabine in the treatment of elderly patients with previously untreated acute myeloid leukemia (AML), in relation to MDR1 status at diagnosis. | van der Holt B; Lowenberg B; Burnett AK; Knauf WU; Shepherd J; Piccaluga PP; Ossenkoppele GJ; Ver...hoef GE; Ferrant A; Crump M; Selleslag D; Theobald M; Fey MF; Vellenga E; Dugan M; Sonneveld P. | 2005-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| Impiego del pegfilgrastim in associazione cn R-CHOP in un paziente critico affetto da un linfoma non Hodgkin aggressivo primitivo del cuore. | Vigna E; Placci A; Laterza C; Agostinelli C; Papayannidis C; Martinelli G; Pileri SA; Piccaluga PP. | 2005-01-01 | CONTINUING EDUCATION IN ONCOLOGIA | - | 1.01 Articolo in rivista | - |
| Fattibilità ed efficacia del regime chemioterapico My-Flaig (mylotarg, fludarabina, citosina arabinsoide, idarubicina e pegfilgrastim) nella terapia della leucemia acuta mieloide. | Piccaluga PP; Vigna E; Martinelli G. | 2005-01-01 | CONTINUING EDUCATION IN ONCOLOGIA | - | 1.01 Articolo in rivista | - |
| Gene Expression analysis of Peripheral T-Cell Lympoma Not Otherwise Specified Reveals the Existance of Two Subgroups Related to Different Celular Counterparts and Recurrent PDGFRA Deregulation. | Piccaluga P.P.; Agostinelli C.; Zupo S.; Califano A.; Went P.; Ascani S.; Basso K.; Facchetti F.;... Falini B.; Ferrarini M.; Gallamini A.; Klein U.; Novero D.; Paulli M.; Tura S.; Zinzani PL.; Baccarani M.; Dalla-Favera R.; Pileri SA. | 2005-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
| Marker expression in Peripheral T-Cell Lymphoma Unspecified: Proposal of a Clinical-Pathologic Prognostic Score. | Piccaluga PP.; Went P.; Agostinelli C.; Gallamini A.; Ascani S.; Sabattini E.; Bacci F.; Falini B....; Motta T.; Paulli M.; Artusi T.; Zinzani PL.; Baccarani M.; Pileri SA. | 2005-01-01 | BLOOD | - | 4.02 Riassunto (Abstract) | - |
| Expression of platelet-derived growth factor receptor alpha in peripheral T-cell lymphoma not otherwise specified | Piccaluga PP; Agostinelli C; Zinzani PL; Baccarani M; Dalla Favera R; Pileri SA. | 2005-01-01 | THE LANCET ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Mini-ICE effectively mobilises peripheral blood stem cells after fludarabine-based regimens in acute myeloid leukaemia. | Mele A; Leopardi G; Sparaventi G; Nicolini G; D'Adamo F; Guiducci B; Barulli S; Malerba L; Strami...gioli S; Talevi N; Politi P; Isidori A; Malagola M; Piccaluga P; Visani G. | 2005-01-01 | EUROPEAN JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
| Multicentre phase III trial on fludarabine, cytarabine (Ara-C), and idarubicin versus idarubicin, Ara-C and etoposide for induction treatment of younger, newly diagnosed acute myeloid leukaemia patients | Russo D; Malagola M; Vivo A; Fiacchini M; Martinelli G; Piccaluga PP; Damiani D; Candoni A; Michi...elutti A; Castelli M; Testoni N; Ottaviani E; Rondoni M; Pricolo G; Mazza P; Zuffa E; Zaccaria A; Raspadori D; Bocchia M; Lauria F; Bonini A; Avanzini P; Gugliotta L; Visani G; Fanin R; Baccarani M | 2005-01-01 | BRITISH JOURNAL OF HAEMATOLOGY | - | 1.01 Articolo in rivista | - |
| The development of more than one histologic type of lymphoma in the same patient is frequent and confers a worse prognosis | Pileri S.A.; Piccaluga P.P.; Sabattini E.; Zinzani P.L. | 2005-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | 348.full.pdf |
| Identification of outcome predictors in diffuse large B-cell lymphoma. Immunohistochemical profiling of homogeneously treated de novo tumors with nodal presentation on tissue micro-arrays. | ZINZANI P.; DIRNHOFER S; SABATTINI E; ALINARI L; PICCALUGA PP; STEFONI V; TANI M; MUSURACA G; MAR...CHI E; FALINI B; BACCARANI M; PILERI SA. | 2005-01-01 | HAEMATOLOGICA | - | 1.01 Articolo in rivista | - |
| Imatinib mesylate in the treatment of c-kit-positive acute myeloid leukemia: is this the real target? | Malagola M; Martinelli G; Rondoni M; Paolini S; Gaitani S; Arpinati M; Piccaluga PP; Amabile M; B...asi C; Ottaviani E; Candoni A; Gottardi E; Cilloni D; Bocchia M; Saglio G; Lauria F; Fanin R; Visani G; Marre MC; Maderna M; Rancati F; Vinaccia V; Russo D; Baccarani M. | 2005-01-01 | BLOOD | - | 1.01 Articolo in rivista | - |
| Alemtuzumab in the treatment of relapsed acute lymphoid leukaemia. | PICCALUGA PP; MARTINELLI G; MALAGOLA M; RONDONI M; BONIFAZI F; BANDINI G; VISANI G; BACCARANI M. | 2005-01-01 | LEUKEMIA | - | 1.01 Articolo in rivista | - |
| Strategies in the treatment of acute myeloid leukemia. | Martinelli G; Malagola M; Rondoni M; Piccaluga PP; Bosi C; Russo D; Baccarani M. | 2005-01-01 | - | s.n | 2.01 Capitolo / saggio in libro | - |
| Cyclophosphamide, pegylated liposomal doxorubicin, vincristine and prednisone (CDOP) plus rituximab is effective and well tolerated in poor performance status elderly patients with non-Hodgkin's lymphoma. | Visani G; Guiducci B; D'Adamo F; Mele A; Nicolini G; Leopardi G; Sparaventi G; Barulli S; Malerba... L; Isidori A; Malagola M; Piccaluga PP. | 2005-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
| Gene expression analysis of peripheral T-cell lymphoma not otherwise specified reveals two distinct subgroups and recurrent PDGFRa deregulation. It's time to take care of peripheral T-cell lymphoma. | Pileri S.A.; Piccaluga PP.; Agostinelli C.; Zupo S.; Carbone A.; Facchetti F.; Falini B.; Ferrari...ni M.; Gallamini A.; Novero D.; Paulli M.; Zinzani P.L.; Dalla Favera R. | 2006-01-01 | HAEMATOLOGICA REPORTS | - | 4.01 Contributo in Atti di convegno | - |
| Gene expression analysis of peripheral t-cell lymphoma not otherwise specified reveals two distint subgroups and recurrent PDGFRa; deregulation. | Pileri S.A.; Piccaluga P.P.; Agostinelli C.; Zupo S.; Facchetti F.; Falini B.; Ferrarini M.; Nove...ro D.; Palli M.; Zinzani P.L.; Dalla Favera R. | 2006-01-01 | PATHOLOGICA | - | 4.02 Riassunto (Abstract) | - |
| Poor outcome of adult acute lymphoblastic leukemia patients carrying the (1;19)(q23;p13) translocation. | Piccaluga PP; Malagola M; Rondoni M; Ottaviani E; Testoni N; Laterza C; Visani G; Pileri SA; Mart...inelli G; Baccarani M. | 2006-01-01 | LEUKEMIA & LYMPHOMA | - | 1.01 Articolo in rivista | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile